Application 004782
- Type
- NDA
- Sponsor
- WYETH PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PREMARIN | ESTROGENS, CONJUGATED | TABLET;ORAL | 1.25MG | Yes | Yes |
| 002 | PREMARIN | ESTROGENS, CONJUGATED | TABLET;ORAL | 2.5MG | No | No |
| 003 | PREMARIN | ESTROGENS, CONJUGATED | TABLET;ORAL | 0.3MG | Yes | No |
| 004 | PREMARIN | ESTROGENS, CONJUGATED | TABLET;ORAL | 0.625MG | Yes | Yes |
| 005 | PREMARIN | ESTROGENS, CONJUGATED | TABLET;ORAL | 0.9MG | Yes | Yes |
| 006 | PREMARIN | ESTROGENS, CONJUGATED | TABLET;ORAL | 0.45MG | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N004782-001 | PREMARIN | ESTROGENS, CONJUGATED | 1.25MG | TABLET / ORAL | AB | RLD, RS, Approved before 1982 | |
| N004782-002 | PREMARIN | ESTROGENS, CONJUGATED | 2.5MG | TABLET / ORAL | Approved before 1982 | ||
| N004782-003 | PREMARIN | ESTROGENS, CONJUGATED | 0.3MG | TABLET / ORAL | AB | RLD, Approved before 1982 | |
| N004782-004 | PREMARIN | ESTROGENS, CONJUGATED | 0.625MG | TABLET / ORAL | AB | RLD, RS, Approved before 1982 | |
| N004782-005 | PREMARIN | ESTROGENS, CONJUGATED | 0.9MG | TABLET / ORAL | AB | RLD, RS | 1984-01-26 |
| N004782-006 | PREMARIN | ESTROGENS, CONJUGATED | 0.45MG | TABLET / ORAL | AB | RLD | 2003-07-16 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N004782-001 | AB |
| N004782-003 | AB |
| N004782-004 | AB |
| N004782-005 | AB |
| N004782-006 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N004782-001 | PREMARIN | 1.25MG | TABLET / ORAL | AB | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N004782-002 | PREMARIN | 2.5MG | TABLET / ORAL | Approved before 1982 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N004782-003 | PREMARIN | 0.3MG | TABLET / ORAL | AB | RLD, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N004782-004 | PREMARIN | 0.625MG | TABLET / ORAL | AB | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N004782-005 | PREMARIN | 0.9MG | TABLET / ORAL | AB | RLD, RS | 1984-01-26 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N004782-006 | PREMARIN | 0.45MG | TABLET / ORAL | AB | RLD | 2003-07-16 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N004782-001 | PREMARIN | 1.25MG | TABLET / ORAL | AB | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N004782-002 | PREMARIN | 2.5MG | TABLET / ORAL | Approved before 1982 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N004782-003 | PREMARIN | 0.3MG | TABLET / ORAL | AB | RLD, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N004782-004 | PREMARIN | 0.625MG | TABLET / ORAL | AB | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N004782-005 | PREMARIN | 0.9MG | TABLET / ORAL | AB | RLD, RS | 1984-01-26 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N004782-006 | PREMARIN | 0.45MG | TABLET / ORAL | AB | RLD | 2003-07-16 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N004782-001 | PREMARIN | 1.25MG | TABLET / ORAL | RLD, RS, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N004782-002 | PREMARIN | 2.5MG | TABLET / ORAL | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N004782-003 | PREMARIN | 0.3MG | TABLET / ORAL | RLD, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N004782-004 | PREMARIN | 0.625MG | TABLET / ORAL | RLD, RS, Approved before 1982 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N004782-005 | PREMARIN | 0.9MG | TABLET / ORAL | RLD, RS | 1984-01-26 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N004782-006 | PREMARIN | 0.45MG | TABLET / ORAL | RLD | 2003-07-16 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N004782-001 | PREMARIN | 1.25MG | TABLET / ORAL | RLD, RS, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N004782-002 | PREMARIN | 2.5MG | TABLET / ORAL | Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N004782-003 | PREMARIN | 0.3MG | TABLET / ORAL | RLD, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N004782-004 | PREMARIN | 0.625MG | TABLET / ORAL | RLD, RS, Approved before 1982 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N004782-005 | PREMARIN | 0.9MG | TABLET / ORAL | RLD, RS | 1984-01-26 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N004782-006 | PREMARIN | 0.45MG | TABLET / ORAL | RLD | 2003-07-16 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N004782-001 | PREMARIN | 1.25MG | TABLET / ORAL | RLD, RS, Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N004782-002 | PREMARIN | 2.5MG | TABLET / ORAL | Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N004782-003 | PREMARIN | 0.3MG | TABLET / ORAL | RLD, Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N004782-004 | PREMARIN | 0.625MG | TABLET / ORAL | RLD, RS, Approved before 1982 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N004782-005 | PREMARIN | 0.9MG | TABLET / ORAL | RLD, RS | 1984-01-26 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N004782-006 | PREMARIN | 0.45MG | TABLET / ORAL | RLD | 2003-07-16 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N004782-001 | PREMARIN | 1.25MG | TABLET / ORAL | RLD, RS, Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N004782-002 | PREMARIN | 2.5MG | TABLET / ORAL | Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N004782-003 | PREMARIN | 0.3MG | TABLET / ORAL | RLD, Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N004782-004 | PREMARIN | 0.625MG | TABLET / ORAL | RLD, RS, Approved before 1982 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N004782-005 | PREMARIN | 0.9MG | TABLET / ORAL | RLD, RS | 1984-01-26 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N004782-006 | PREMARIN | 0.45MG | TABLET / ORAL | RLD | 2003-07-16 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N004782-001 | PREMARIN | 1.25MG | TABLET / ORAL | RLD, RS, Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N004782-002 | PREMARIN | 2.5MG | TABLET / ORAL | Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N004782-003 | PREMARIN | 0.3MG | TABLET / ORAL | RLD, Approved before 1982 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N004782-004 | PREMARIN | 0.625MG | TABLET / ORAL | RLD, RS, Approved before 1982 | 2680178bc6a6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N004782-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N004782-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N004782-004 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N004782-005 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N004782-006 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N004782-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N004782-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N004782-004 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N004782-005 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N004782-006 | AB | 1 | 31067a03dcf5… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N004782-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N004782-003 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N004782-004 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N004782-005 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N004782-006 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Premarin | ESTROGENS, CONJUGATED | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 258e1602-a3cf-4ccc-ca80-73dbbfb812ff | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | 004782 NDA004782 0046-1101 0046-1102 0046-1103 0046-1100 0046-1104 |
| Conjugated Estrogens | ESTROGENS, CONJUGATED | Prasco Laboratories | ce793f9e-0c20-43e6-9dc0-064e5c82e243 | 2026-02-27 | Boxed warning, Warnings, Adverse reactions | 004782 NDA004782 |
| Premarin | ESTROGENS, CONJUGATED | A-S Medication Solutions | a3b86b85-8923-42ae-aa31-a66a6e090327 | 2025-04-02 | Boxed warning, Warnings, Adverse reactions | 004782 NDA004782 50090-0167 |
| PREMARIN | ESTROGENS, CONJUGATED | A-S Medication Solutions | 2b4dbb7c-4e6d-47c9-b940-fef91f1f4a05 | 2024-02-04 | Boxed warning, Warnings, Adverse reactions | 004782 NDA004782 50090-1853 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0046-1100 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1100 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1100 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1100 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1100 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1101 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1101 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1101 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1101 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1101 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1102 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1102 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1102 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1102 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1102 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1103 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1103 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1103 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1103 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1103 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1104 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1104 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1104 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1104 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 0046-1104 | Premarin | estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA | Current |
| 43353-687 | Premarin | conjugated estrogens | Aphena Pharma Solutions - Tennessee, Inc. | NDA | Current |
| 43353-688 | Premarin | conjugated estrogens | Aphena Pharma Solutions - Tennessee, Inc. | NDA | Current |
| 50090-0167 | Premarin | estrogens, conjugated | A-S Medication Solutions | NDA | Current |
| 50090-0167 | Premarin | estrogens, conjugated | A-S Medication Solutions | NDA | Current |
| 50090-0167 | Premarin | estrogens, conjugated | A-S Medication Solutions | NDA | Current |
| 50090-0167 | Premarin | estrogens, conjugated | A-S Medication Solutions | NDA | Current |
| 50090-1853 | Premarin | estrogens, conjugated | A-S Medication Solutions | NDA | Current |
| 53808-0770 | Premarin | conjugated estrogens | State of Florida DOH Central Pharmacy | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 82080 | SUPPL | 2025-05-01 |
| 81995 | SUPPL | 2025-04-25 |
| 77561 | SUPPL | 2024-02-20 |
| 77514 | SUPPL | 2024-02-16 |
| 63858 | SUPPL | 2020-07-13 |
| 50350 | SUPPL | 2017-11-09 |
| 32925 | SUPPL | 2014-12-10 |
| 10 | SUPPL | 2014-12-04 |
| 32924 | SUPPL | 2011-11-01 |
| 32923 | SUPPL | 2011-11-01 |
| 10673 | SUPPL | 2011-11-01 |
| 57 | SUPPL | 2011-10-31 |
| 9 | SUPPL | 2011-10-31 |
| 8 | SUPPL | 2011-10-31 |
| 43992 | ORIG | 2009-06-02 |
| 32922 | SUPPL | 2008-03-05 |
| 56 | SUPPL | 2008-03-05 |
| 40642 | SUPPL | 2007-04-09 |
| 20003 | SUPPL | 2007-04-09 |
| 7 | SUPPL | 2006-09-18 |
| 32921 | SUPPL | 2006-09-12 |
| 32920 | SUPPL | 2006-04-25 |
| 55 | SUPPL | 2006-04-25 |
| 10672 | SUPPL | 2005-11-03 |
| 6 | SUPPL | 2005-11-03 |
| 32919 | SUPPL | 2005-08-04 |
| 5 | SUPPL | 2005-08-04 |
| 32918 | SUPPL | 2005-04-12 |
| 10671 | SUPPL | 2005-04-12 |
| 54 | SUPPL | 2005-04-12 |
| 4 | SUPPL | 2005-04-12 |
| 10669 | SUPPL | 2004-11-17 |
| 10670 | SUPPL | 2004-08-31 |
| 53 | SUPPL | 2004-08-31 |
| 10668 | SUPPL | 2004-05-04 |
| 52 | SUPPL | 2004-04-29 |
| 51 | SUPPL | 2004-04-29 |
| 1 | SUPPL | 2003-07-28 |
| 49 | SUPPL | 2003-05-16 |
| 3 | SUPPL | 2003-05-16 |
| 32917 | SUPPL | 2003-04-30 |
| 10665 | SUPPL | 2003-04-28 |
| 10667 | SUPPL | 2003-01-07 |
| 50 | SUPPL | 2003-01-07 |
| 10666 | SUPPL | 2002-11-27 |
| 2 | SUPPL | 2002-11-27 |
| 40641 | SUPPL | 1998-09-08 |
| 48 | SUPPL | 1998-09-08 |